|
1
|
Kanth P and Inadomi JM: Screening and
prevention of colorectal cancer. BMJ. 374:n18552021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dekker E, Tanis PJ, Vleugels JLA, Kasi PM
and Wallace MB: Colorectal cancer. Lancet. 394:1467–1480. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Biller LH and Schrag D: Diagnosis and
treatment of metastatic colorectal cancer: A review. JAMA.
325:669–685. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li N, Lu B, Luo C, Cai J, Lu M, Zhang Y,
Chen H and Dai M: Incidence, mortality, survival, risk factor and
screening of colorectal cancer: A comparison among China, Europe,
and northern America. Cancer Lett. 522:255–268. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhou L, Zhu Y, Sun D and Zhang Q: Emerging
roles of long non-coding RNAs in the tumor microenvironment. Int J
Biol Sci. 16:2094–2103. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chi Y, Wang D, Wang J, Yu W and Yang J:
Long non-coding RNA in the pathogenesis of cancers. Cells.
8:10152019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhao Z, Sun W, Guo Z, Zhang J, Yu H and
Liu B: Mechanisms of lncRNA/microRNA interactions in angiogenesis.
Life Sci. 254:1169002020. View Article : Google Scholar
|
|
9
|
Winkle M, El-Daly SM, Fabbri M and Calin
GA: Noncoding RNA therapeutics - challenges and potential
solutions. Nat Rev Drug Discov. 20:629–651. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chan JJ and Tay Y: Noncoding RNA: RNA
regulatory networks in cancer. Int J Mol Sci. 19:13102018.
View Article : Google Scholar
|
|
11
|
Tang J, Yan T, Bao Y, Shen C, Yu C, Zhu X,
Tian X, Guo F, Liang Q, Liu Q, et al: LncRNA GLCC1 promotes
colorectal carcinogenesis and glucose metabolism by stabilizing
c-Myc. Nat Commun. 10:34992019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lin X, Zhuang S, Chen X, Du J, Zhong L,
Ding J, Wang L, Yi J, Hu G, Tang G, et al: lncRNA ITGB8-AS1
functions as a ceRNA to promote colorectal cancer growth and
migration through integrin-mediated focal adhesion signaling. Mol
Ther. 30:688–702. 2022. View Article : Google Scholar :
|
|
13
|
Hu XT, Xing W, Zhao RS, Tan Y, Wu XF, Ao
LQ, Li Z, Yao MW, Yuan M, Guo W, et al: HDAC2 inhibits EMT-mediated
cancer metastasis by downregulating the long noncoding RNA H19 in
colorectal cancer. J Exp Clin Cancer Res. 39:2702020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen J, Song Y, Li M, Zhang Y, Lin T, Sun
J, Wang D, Liu Y, Guo J and Yu W: Comprehensive analysis of ceRNA
networks reveals prognostic lncRNAs related to immune infiltration
in colorectal cancer. BMC Cancer. 21:2552021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Karreth FA and Pandolfi PP: ceRNA
cross-talk in cancer: When ce-bling rivalries go awry. Cancer
Discov. 3:1113–1121. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu AM, He CJ, Tuerxun Z and Anikezi A:
FAM172A affects cell proliferation and apoptosis not by targeting
β-tubulin in HepG2 cells. Transl Cancer Res. 9:5637–5644. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Narayanankutty A: PI3K/Akt/mTOR pathway as
a therapeutic target for colorectal cancer: A review of preclinical
and clinical evidence. Curr Drug Targets. 20:1217–1226. 2019.
View Article : Google Scholar
|
|
18
|
Vu LP, Cheng Y and Kharas MG: The biology
of m6A RNA methylation in normal and malignant
hematopoiesis. Cancer Discov. 9:25–33. 2019. View Article : Google Scholar
|
|
19
|
Ianniello Z, Paiardini A and Fatica A:
N6-Methyladenosine (m6A): A promising new
molecular target in acute myeloid leukemia. Front Oncol. 9:2512019.
View Article : Google Scholar
|
|
20
|
Xiang S, Liang X, Yin S, Liu J and Xiang
Z: N6-methyladenosine methyltransferase METTL3 promotes colorectal
cancer cell proliferation through enhancing MYC expression. Am J
Transl Res. 12:1789–1806. 2020.PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
22
|
Li HB, Tong J, Zhu S, Batista PJ, Duffy
EE, Zhao J, Bailis W, Cao G, Kroehling L, Chen Y, et al:
m6A mRNA methylation controls T cell homeostasis by
targeting the IL-7/STAT5/SOCS pathways. Nature. 548:338–342. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pfaff J, Hennig J, Herzog F, Aebersold R,
Sattler M, Niessing D and Meister G: Structural features of
Argonaute-GW182 protein interactions. Proc Natl Acad Sci USA.
110:E3770–E3779. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hicks JA, Li L, Matsui M, Chu Y, Volkov O,
Johnson KC and Corey DR: Human GW182 paralogs are the central
organizers for RNA-mediated control of transcription. Cell Rep.
20:1543–1552. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Smolarz B, Zadrożna-Nowak A and Romanowicz
H: The Role of lncRNA in the development of tumors, including
breast cancer. Int J Mol Sci. 22:84272021. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ghafouri-Fard S, Abak A, Tondro Anamag F,
Shoorei H, Majidpoor J and Taheri M: The emerging role of
non-coding RNAs in the regulation of PI3K/AKT pathway in the
carcinogenesis process. Biomed Pharmacother. 137:1112792021.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
He Q, Long J, Yin Y, Li Y, Lei X, Li Z and
Zhu W: Emerging roles of lncRNAs in the formation and progression
of colorectal cancer. Front Oncol. 9:15422019. View Article : Google Scholar
|
|
28
|
Statello L, Guo CJ, Chen LL and Huarte M:
Gene regulation by long non-coding RNAs and its biological
functions. Nat Rev Mol Cell Biol. 22:96–118. 2021. View Article : Google Scholar
|
|
29
|
Smillie CL, Sirey T and Ponting CP:
Complexities of post-transcriptional regulation and the modeling of
ceRNA crosstalk. Crit Rev Biochem Mol Biol. 53:231–245. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang XZ, Cheng TT, He QJ, Lei ZY, Chi J,
Tang Z, Liao QX, Zhang H, Zeng LS and Cui SZ: LINC01133 as ceRNA
inhibits gastric cancer progression by sponging miR-106a-3p to
regulate APC expression and the Wnt/β-catenin pathway. Mol Cancer.
17:1262018. View Article : Google Scholar
|
|
31
|
Xu M, Chen X, Lin K, Zeng K, Liu X, Xu X,
Pan B, Xu T, Sun L, He B, et al: lncRNA SNHG6 regulates EZH2
expression by sponging miR-26a/b and miR-214 in colorectal cancer.
J Hematol Oncol. 12:32019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen T, Lei S, Zeng Z, Zhang J, Xue Y, Sun
Y, Lan J, Xu S, Mao D and Guo B: Linc00261 inhibits metastasis and
the WNT signaling pathway of pancreatic cancer by regulating a
miR-552-5p/FOXO3 axis. Oncol Rep. 43:930–942. 2020.PubMed/NCBI
|
|
33
|
Cai W, Xu Y, Yin J, Zuo W and Su Z:
miR-552-5p facilitates osteosarcoma cell proliferation and
metastasis by targeting WIF1. Exp Ther Med. 17:3781–3788.
2019.PubMed/NCBI
|
|
34
|
Liu W, Qian K, Wei X, Deng H, Zhao B, Chen
Q, Zhang J and Liu H: miR-27a promotes proliferation, migration,
and invasion of colorectal cancer by targeting FAM172A and acts as
a diagnostic and prognostic biomarker. Oncol Rep. 37:3554–3564.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen Y, Liu P, Shen D, Liu H, Xu L, Wang
J, Shen D, Sun H and Wu H: FAM172A inhibits EMT in pancreatic
cancer via ERK-MAPK signaling. Biol Open. 9:bio0484622020.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu HT, Zou YX, Zhu WJ, Sen-Liu, Zhang GH,
Ma RR, Guo XY and Gao P: lncRNA THAP7-AS1, transcriptionally
activated by SP1 and post-transcriptionally stabilized by
METTL3-mediated m6A modification, exerts oncogenic properties by
improving CUL4B entry into the nucleus. Cell Death Differ.
29:627–641. 2022. View Article : Google Scholar :
|
|
37
|
Deng X, Su R, Weng H, Huang H, Li Z and
Chen J: RNA N6-methyladenosine modification in cancers:
Current status and perspectives. Cell Res. 28:507–517. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Roundtree IA, Evans ME, Pan T and He C:
Dynamic RNA modifications in gene expression regulation. Cell.
169:1187–1200. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Peng W, Li J, Chen R, Gu Q, Yang P, Qian
W, Ji D, Wang Q, Zhang Z, Tang J and Sun Y: Upregulated METTL3
promotes metastasis of colorectal cancer via miR-1246/SPRED2/MAPK
signaling pathway. J Exp Clin Cancer Res. 38:3932019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhou D, Tang W, Xu Y, Xu Y, Xu B, Fu S,
Wang Y, Chen F, Chen Y, Han Y and Wang G: METTL3/YTHDF2 m6A axis
accelerates colorectal carcinogenesis through epigenetically
suppressing YPEL5. Mol Oncol. 15:2172–2184. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liu W, Liu C, You J, Chen Z, Qian C, Lin
W, Yu L, Ye L, Zhao L and Zhou R: Pan-cancer analysis identifies
YTHDF2 as an immunotherapeutic and prognostic biomarker. Front Cell
Dev Biol. 10:9542142022. View Article : Google Scholar : PubMed/NCBI
|
